Anticoccidial Drugs Market Size & Share 2024 – 2032

Anticoccidial Drugs Market Size

Anticoccidial Drugs Market size was valued at USD 183.1 million in 2023 and is anticipated to grow at a CAGR of 4.1% from 2024 and 2032. One of the key drivers is the increasing demand for poultry products, such as meat and eggs, due to the growing demand for protein-rich diets.

This has led to a higher incidence of coccidiosis in poultry, necessitating the use of anticoccidial drugs for prevention and treatment. Additionally, the intensification of poultry farming practices, aimed at meeting the rising demand, has created a conducive environment for the spread of coccidiosis, further fueling the demand for these drugs. Furthermore, growing awareness among farmers about the economic benefits of using anticoccidial drugs, such as improved feed conversion rates and reduced mortality rates, is also contributing to market growth.
 

Anticoccidial drugs are pharmaceutical agents used to prevent and treat coccidiosis, a parasitic disease caused by protozoa of the genus Eimeria. This protozoon infects the intestinal tracts of animals, poultry, cattle, sheep, goats, swine, and companion animals. Coccidiosis can cause significant economic losses in the livestock industry due to decreased productivity, weight loss, and mortality.
 

Anticoccidial Drugs Market Trends

• The global livestock population is expanding to meet the rising demand for animal products. As the number of livestock animals increases, so does the need for effective disease management practices to ensure their health and productivity
  .
• The higher concentration of animals in farming operations increases the risk of disease transmission, including coccidiosis, making the use of anticoccidial drugs essential. This growing livestock population requires robust and efficient disease prevention measures, thereby boosting the demand for anticoccidial drugs.
   
• As farming practices become more intensive and livestock densities increases, the prevalence and spread of coccidiosis is also escalating.
   
• Additionally, the high cost associated with coccidiosis outbreaks necessitates effective prevention and treatment strategies, thereby driving the demand for anticoccidial drugs to maintain livestock health and productivity.
   

Anticoccidial Drugs Market Analysis

Based on drug class, the market is segmented into synthetic compounds and polyether antibiotics or ionophores. The synthetic compounds segment dominated the market in 2023 with a market share of 62.1%.
 

• The synthetic compounds segment holds the highest market share in the market due to its high efficacy and broad spectrum of activity against various coccidia species.
   
• Moreover, the versatility of synthetic compounds, available in various forms like animal feed additives, oral solutions, and injectables, allows for flexible application methods tailored to different livestock management practices.
   
• Furthermore, cost-effectiveness and availability are additional factors contributing to the dominance of synthetic compounds in the market.
   

Based on drug action, the anticoccidial drugs market is classified into coccidiostatic and coccidiocidal. The coccidiostatic segment dominated the global market and is anticipated to showcase growth at a CAGR 3.9% between 2024 – 2032.
 

• Coccidiostatic drugs have been widely used and proven effective in controlling coccidiosis in poultry and livestock. Their widespread availability and effectiveness contribute to their high usage and market share.
   
• Further, continued regulatory approval, ongoing research and development efforts aimed at enhancing their efficacy and safety, and the proactive preventive approach associated with their usage collectively sustain the dominance of coccidiostatic drugs in the market.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on animal type, the anticoccidial drugs market is divided into companion animals and livestock animals. The companion animals segment held highest market share and was valued at USD 104.7 million in 2023. The companion animals’ segment is further segmented into dogs, cats, and other companion animals.
 

• There has been a significant increase in the number of companion animals, such as dogs and cats, kept as pets worldwide. This rise in pet ownership has led to a higher demand for preventive and therapeutic treatments against diseases like coccidiosis in these animals.
   
• Additionally, owners are increasingly investing in the health and well-being of their pets, driving the demand for effective anticoccidial drugs.
   
• Moreover, advancements in veterinary medicine and an increasing awareness of the health risks associated with coccidiosis in companion animals have propelled the growth of this segment.
   

Based on distribution channel, the anticoccidial drugs market is categorized into veterinary hospitals & pharmacies, retail pharmacies, and other distribution channels. The veterinary hospitals & pharmacies segment accounted for USD 83.7 million in 2023 and is expected to reach USD 118.8 million by 2032.
 

• Veterinary hospitals & pharmacies serve as primary point of access for pet owners and livestock producers to obtain veterinary medications, including anticoccidial drugs. These establishments often have a wide range of products available, making them convenient sources for purchasing these medications.
   
• Moreover, the growing emphasis on preventive healthcare for animals, coupled with increasing awareness on the importance of disease management, contributes to the steady demand for anticoccidial drugs from these establishments.
   

North America anticoccidial drugs market is projected to grow at a CAGR of 3.9% over the forecast period to reach USD 106.8 million by 2032.
 

• The region boasts a substantial livestock and poultry industry, where coccidiosis is a prevalent concern. This drives a significant demand for anticoccidial drugs to manage and prevent the disease in animals raised for meat, eggs, and dairy production.
   
• Additionally, North America's advanced animal healthcare infrastructure, including clinics, hospitals, and research institutions, supports the diagnosis, treatment, and prevention of coccidiosis, further fueling the demand for these medications.
   

The U.S. anticoccidial drugs market was valued at USD 70.3 million and is anticipated to experience growth at 3.8% CAGR over the coming years.
 

• The country's large livestock population, including poultry and cattle, creates a substantial demand for anticoccidial drugs to prevent and control coccidiosis.
   
• Additionally, the presence of key players in the animal health industry, advanced veterinary healthcare infrastructure, and stringent regulations ensuring the quality and safety of animal health products contribute to the dominance of the U.S. market.
   

Germany anticoccidial drugs market is anticipated to witness lucrative growth in near future.
 

• The country boasts a robust veterinary healthcare infrastructure with advanced clinics, hospitals, and research institutions, facilitating the adoption of anticoccidial drugs.
   
• Additionally, Germany's stringent regulations and standards regarding animal welfare and health drive the demand for safe and effective veterinary medications, further enhancing the market growth.
   

India anticoccidial drugs market is anticipated to showcase significant growth from 2024 - 2032.
 

• A large livestock population in the country, increases the demand for anticoccidial drugs. For instance, according to 20th Livestock Census, the total number of cattle in India was estimated to be 192.49 million in 2019.
   
• Farmers and livestock producers in India recognize the economic importance of controlling diseases like coccidiosis, as they can lead to reduced growth rates, decreased milk production, and even mortality among cattle.
   
• As a result, there is a growing demand for anticoccidial drugs to manage and prevent the disease in cattle, thereby boosting the market growth.
   

Anticoccidial Drugs Market Share

The market is characterized by several key players are vying for market share through strategies such as product innovation, partnerships, mergers, and acquisitions. Companies such as Zoetis Inc., Elanco, Merck & Co. Inc., Bayer AG, and Ceva are among the prominent players driving innovation and market growth through the development of novel anticoccidial drugs.
 

Anticoccidial Drugs Market Companies

Prominent players operating in the anticoccidial drugs industry include:

• Bayer AG
• Boehringer Ingelheim International GmbH
• Ceva
• Cronus Pharma LLC
• Elanco Animal Health Incorporated
• Huvepharma EOOD
• Impextraco NV
• Merck & Co., Inc.
• Phibro Animal Health Corporation
• Vetoquinol SA
• Virbac SA
• Zoetis Inc.
   

Anticoccidial Drugs Industry News:

• In May 2019, Bayer launched Baycox, an iron injection combination in Europe for protecting piglets from coccidiosis and iron deficiency. This product launch helped the company to broaden its product portfolio and generate revenue.
   

The anticoccidial drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Drug Class

• Synthetic compounds
• Polyether antibiotics or ionophores

Market, By Drug Action

• Coccidiostatic
• Coccidiocidal

Market, By Animal Type

• Companion animals
  • Dogs
  • Cats
  • Other companion animals
• Livestock animals
  • Cattle
  • Poultry
  • Other livestock animals

Market, By Distribution Channel

• Veterinary hospitals and pharmacies
• Retail pharmacies
• Other distribution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa